Prognostic value of growth differentiation factor 15 in older patients undergoing emergency abdominal surgery: a prospective observational study at a tertiary hospital
Background Emergency abdominal surgery in frail older patients carries a high risk of mortality and cardiovascular complications. Growth differentiation factor 15 (GDF-15) is a strong prognostic marker across different patient populations and may improve perioperative risk stratification. We assessed associations between preoperative GDF-15 concentrations and postoperative outcomes in older patients undergoing emergency abdominal surgery. Methods This preplanned secondary biomarker substudy of the ProPEL cohort included 142 patients aged ≥75 yr undergoing emergency abdominal surgery between January 2020 and April 2021. The primary endpoint was 30-day all-cause mortality. Secondary endpoints were 90-day mortality and 30-day mortality or major adverse cardiac events (MACEs). Intraoperative blood transfusion was added as a post hoc exploratory analysis. Results Overall, 30-day all-cause mortality was 12% (17/142). Mortality was 31% (11/36) in the highest GDF-15 quartile compared with 6% (2/35 or 2/36) in each of the lower quartiles. Each doubling of GDF-15 was associated with increased 30-day mortality (hazard ratio: 1.75, 95% confidence interval: 1.15–2.66, P =0.009) independent of age, sex, and Clinical Frailty Scale, and in a model adjusted for high-sensitivity cardiac troponin T hazard ratio 1.65 (1.03–2.65), P=0.037. GDF-15 predicted 30-day death or MACE, adjusted for age, sex, and Clinical Frailty Scale, but not after adjusting for high-sensitivity cardiac troponin T. Associations with 90-day mortality were attenuated after adjustment. A doubling of GDF-15 concentrations was associated with an adjusted odds ratio of 1.90 (95% confidence interval 1.29–2.78, P =0.001) for intraoperative blood transfusion. Conclusions GDF-15 was associated with 30-day mortality and the need for blood transfusion in older adults undergoing acute abdominal surgery.
Authors
- Kristin Moberg Aakre (ORCID: https://orcid.org/0000-0002-7340-6736)
- Gard M. S. Myrmel (ORCID: https://orcid.org/0000-0003-4885-1085)
- Erik Wilhelm Vinnes (ORCID: https://orcid.org/0000-0001-8374-0554)
- Ib Jammer (ORCID: https://orcid.org/0000-0001-6759-3929)
- Elin Kismul Aakre (ORCID: https://orcid.org/0000-0002-3131-8914)
- Jørn Vegard Sagen (ORCID: https://orcid.org/0000-0002-8795-0732)
Institutions
- University of Oslo (NO)
- Akershus University Hospital (NO)
- Haukeland University Hospital (NO)
- University of Bergen (NO)
Publication Details
- Journal
- BJA Open
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.bjao.2026.100894
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Helse Vest
- Haukeland Universitetssjukehus
- Roche Diagnostics